Bruker Corp [BRKR] stock is trading at $40.66, up 3.70%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BRKR shares have gain 8.72% over the last week, with a monthly amount glided 8.37%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bruker Corp [NASDAQ: BRKR] stock has seen the most recent analyst activity on May 22, 2025, when Citigroup downgraded its rating to a Neutral but kept the price target unchanged to $40 for it. Previously, Guggenheim started tracking the stock with Buy rating on December 19, 2024, and set its price target to $72. On December 10, 2024, UBS initiated with a Neutral rating and assigned a price target of $66 on the stock. Goldman upgraded its rating to a Neutral but stick to its price target of $60 on December 05, 2024. Barclays initiated its recommendation with a Overweight and recommended $75 as its price target on October 15, 2024. Wolfe Research downgraded its rating to Peer Perform for this stock on September 30, 2024. In a note dated August 28, 2024, Wells Fargo initiated an Overweight rating and provided a target price of $78 on this stock.
Bruker Corp [BRKR] stock has fluctuated between $34.10 and $72.94 over the past year. Currently, Wall Street analysts expect the stock to reach $72 within the next 12 months. Bruker Corp [NASDAQ: BRKR] shares were valued at $40.66 at the most recent close of the market. An investor can expect a potential return of 77.08% based on the average BRKR price forecast.
Analyzing the BRKR fundamentals
Bruker Corp [NASDAQ:BRKR] reported sales of 3.45B for the trailing twelve months, which represents a growth of 11.04%. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.04 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Bruker Corp’s Current Ratio is 1.57. Further, the Quick Ratio stands at 0.74, while the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 1.79, the price to book ratio is 3.39 and price to earnings (TTM) ratio is 77.43.
Transactions by insiders
Recent insider trading involved LAUKIEN FRANK H, PRESIDENT & CEO, that happened on Jun 06 ’25 when 2608.0 shares were purchased. Chief Accounting Officer, Bures Thomas completed a deal on Mar 10 ’25 to buy 500.0 shares. Meanwhile, PRESIDENT & CEO LAUKIEN FRANK H bought 20000.0 shares on Feb 18 ’25.
